Investor Ideas #Potcasts 529, #Cannabis News and #Stocks on the Move; (TSXV: $KHRN.V) (OTCQX: $KHRNF) (NASDAQ: $TLRY) (OTC: $ZAAG) (CSE: $CRFT.C) (TSXV: $NDVA.V)
Delta, Kelowna, BC, February 10, 2020 (Investorideas.com Newswire) www.Investorideas.com, a global news source covering leading sectors including marijuana and hemp stocks and its potcast site, www.potcasts.ca release today’s podcast edition of cannabis news and stocks to watch plus insight from thought leaders and experts.
Listen to the podcast:
https://www.investorideas.com/Audio/Podcasts/2021/021021-StocksToWatch.mp3
Read this in full at https://www.investorideas.com/news/2021/cannabis-potcasts/02101KHRN-TLRY-ZAAG-CRFT-NDVA.asp
Hear the investor ideas potcast on Spotify
Hear Investor ideas cannabis potcast on iTunes
Today’s podcast overview/transcript:
Good afternoon and welcome to another episode of Investorideas.com "Potcast" featuring cannabis news, stocks to watch as well as insights from thought leaders and experts.
In today’s podcast we will be looking at a few public and private company announcements.
Khiron Life Sciences Corp. (TSXV: KHRN) (OTCQX: KHRNF), a vertically integrated cannabis leader with core operations in Latin America and Europe, today announced that it will launch two additional small-format Zerenia™ clinics in Q1 2021. The new clinics, which follow on the successful launch of the Company's first small-format clinic in Medellin, will be located in high-traffic, medical-hub neighbourhoods in two of Colombia's largest metropolitan centres outside of Bogota.
The two new small-format Zerenia™ clinics, which are expected to open in early March, will expand Khiron's network to six clinics, improving regional access to the Company's clinic services and medical cannabis products for patients across the country.
"Since opening our first small-format Zerenia™ clinic in Medellin in December 2020, we have seen tremendous patient demand for our products and services. Patient consultations and prescriptions continue to accelerate, with eight of every ten patients now receiving a paid prescription, despite operating in pandemic conditions. Having proven the demand for local physicians and the robust economics associated with small-format clinics, Khiron will continue to expand its regional presence, in Colombia and beyond," comments Alvaro Torres, Khiron CEO and Director.
Supported by Khiron's larger clinics licences, the two new Zerenia™ small-format clinics will provide consultations both in person and through the Doctor Zerenia™ telemedicine platform, connecting patients with medical specialists trained in the ethical, safe, and responsible prescription of cannabis-based medications. Medical cannabis continues to be validated as an effective treatment of pathologies such as chronic pain, anxiety, insomnia, depression, headache, epilepsy, and Parkinson's Disease.
Econic Crop Solutions Inc, a Division of ZA Group Inc. (OTC: ZAAG) announced that it has commenced the manufacturing and assembly of the next 10 medical cannabis grow pods. Once completed, these pods will be strategically placed within the first three First Nations communities where the company's previously reported grow operations are already underway. The company-owned pod manufacturing plant is located at 7607 Edgar Industrial Drive in Red Deer, Alberta. Plant manager, Brian Cruickshank, reported that the next 10 pods are being completed sequentially with the first ones ready for deployment in early March with all 10 ready for deployment by the end of March. He further stated that the manufacturing plant is able to produce these pods at a rate of 10 per month on an ongoing basis.
As previously reported, harvesting has been underway since late January on the three pilot demonstration pods for three separate First Nations communities. The results appear to be on target with anticipated revenues of $100,000 per pod within a three month growing season. The deployment of the 10 newly assembled pods starting in early March and continuing onward illustrates exponential growth potential even within the first year of the company's operations. At the same time, the orderly and incremental rollout of grow pod facilities allows the company to fine tune the grow facilities as it expands.
When asked to provide his comments, Wade Eno, CEO of Econic stated, "The excitement amongst our First Nations business colleagues to see these grow pods come into their communities is tremendous. Our manufacturing plant could not keep up with the volume demand we are experiencing. The three communities for which we are completing the first harvest have all requested 100 pods each and new requests from other First Nations communities are being processed weekly. We believe the rollout of 10 pods per month will give us the ability to respond quickly to any challenges along the way while we look forward to revenues of $1,000,000 per quarter from each group of 10 pods."
John Morgan, President of ZA Group, stated, "I support the strategy reflected in the comments by Mr. Eno. The medical cannabis industry has seen exponential growth in the past several years and the potential in this industry remains very high. The companies experiencing the best success are those which start small and then expand in a controlled fashion from the revenues accrued. Econics has assembled the team to build and operate the grow pods, and it has a demonstrated network of enthusiastic First Nations community partners that confirms unlimited expansion potential."
BC Craft Supply Co. Ltd. (CSE:CRFT) announced a new product into its supply chain from renowned BC micro cultivator, Dunn Cannabis Inc.. 24kg of Screwhead has been purchased by BC Craft and shipped to Indiva Limited (TSXV:NDVA) (OTCQX:NDVAF) for processing into Indiva’s new premium brand, Artisan Batch. The crystal covered buds are processed into sleek 3.5 gram jars which are now available in BC through private and provincial retailers. Artisan Batch features strains from BC Craft’s small scale and micro cultivators across Canada and is quickly becoming a top craft brand in today’s recreational market.
Dunn Cannabis is based out of Abbotsford, British Columbia and is run by a legacy production team of 3 with over 42 years of cannabis experience. “We’re one of the first micros in BC and we’re fresh out of the gate with a new business that is very unique within the existing market,” says Robert Logan Dunn, owner of Dunn Cannabis. “We’re unique in that we’re production-attentive, focussed on what experienced consumers expect and provide new consumers a product they will feel confident in. Bringing this clarity as a legacy producer is a great opportunity to show how this can work. Dunn Cannabis is different, we sacrifice larger yielding cultivars with genetics that we know are going to dazzle the consumer.” Dunn and his team have refined their cultivation methods for decades to create high-grade, small-batch cannabis that the recreational market has been burning for.
Artisan Batch products have had tremendous success with many provincial distributors selling out within 24 hours, supply has been difficult to keep on the shelf. It is hard to miss the high praise and accolades from cannabis reviewers and cannabis consumers on social media platforms. This feedback solidifies the BC Craft business model of bringing legacy small-scale cultivators to thrive in today’s regulated market.
Matthew Watters, CEO of BC Craft further stated, “Dunn Cannabis continues to delight consumers in the recreational market with their high quality, artisanal flower. We are excited to bring another new cultivar to market, and thus far the consumer feedback has been extremely positive.”
The Company also announces that it has issued 72,000 incentive stock options to an officer of the Company at a price of $0.135 per common share for a period of five years, pursuant to its Stock Option Plan.
Tilray Inc. (NASDAQ: TLRY), a global pioneer in cannabis research, cultivation, production, and distribution, announced yesterday that it has established an agreement with Grow Pharma to import and distribute Tilray’s medical cannabis products into the United Kingdom (UK). This agreement allows Tilray to provide authorized UK patients in need with a locally maintained supply of medical cannabis solutions.
Tilray expects to have a range of GMP-certified, medical cannabis products available for patients in the UK by March 2021. Patients looking to use medical cannabis will have access to Tilray products in the UK by obtaining prescriptions through private practice or the National Health Service (NHS).
Brendan Kennedy, Tilray’s Chief Executive Officer, said, "This partnership with Grow Pharma provides patients in need access to a sustained supply of GMP-certified, high-quality medical cannabis and is an important step in improving access in the UK. Tilray will continue to advocate for reasonable patient access to medical cannabis in Europe and countries around the world."
Sascha Mielcarek, Managing Director of Tilray Europe, said, "As demand continues to ramp up in the UK, Tilray is well-positioned to be a leading supplier of medical cannabis products. Regulations are progressing as more and more countries across Europe are recognizing the benefits of medical cannabis and its potential to improve patients’ quality of life. We’re pleased to reaffirm our commitment to delivering medical cannabis to patients in the UK and look forward to offering a variety of GMP-certified, pharmaceutical-grade products in the coming months."
Pierre van Weperen, Chief Executive Officer of Grow Pharma, said, "We’re proud to join forces with Tilray and provide patients in need with a secure and sustainable supply of the highest-quality medical cannabis products in the UK."
Investor ideas reminds all listeners to read our disclaimers and disclosures on the Investorideas.com website and that this podcast is not an endorsement to buy products or services or securities. Investors are reminded all investment involves risk and possible loss of investment.
Learn more about our cannabis podcasts at https://www.investorideas.com/Audio/Potcasts.asp
Investors can trade these stocks and other ideas on our site using our list of top stock trading apps including Robinhood , Acorn, Stash and others.
To hear more Investorideas.com podcasts visit: https://www.investorideas.com/Audio/.
Investorideas.com podcasts are also available on iTunes, Spotify, Google Play Music, Stitcher, Spreaker, YouTube via Spreaker, iHeartradio and Tunein.
Potcasts is now a certified word mark Trademark on the blockchain through Cognate, Inc. CM Certification-Registration Number: 10468217708
About Investorideas.com - News that Inspires Big Investing Ideas
Investorideas.com is a recognized news source publishing third party news, research and original financial content. Learn about investing in stocks and sector trends with our news alerts, articles, podcasts and videos, looking at cannabis, crypto, AI and IoT, mining, sports biotech, water, renewable energy and more. Investor Idea’s original branded content includes the following podcasts and columns : Crypto Corner , Play by Play sports and stock news column, Investor Ideas Potcasts Cannabis News and Stocks on the Move podcast and column, Cleantech and Climate Change , Exploring Mining the AI Eye .
Disclaimer/Disclosure: Investorideas.com is a digital publisher of third party sourced news, articles and equity research as well as creates original content, including video, interviews and articles. Original content created by investorideas is protected by copyright laws other than syndication rights. Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investing involves risk and possible losses. This site is currently compensated for news publication and distribution, social media and marketing, content creation and more. Disclosure is posted for each compensated news release, content published /created if required but otherwise the news was not compensated for and was published for the sole interest of our readers and followers. Contact management and IR of each company directly regarding specific questions. More disclaimer info: https://www.investorideas.com/About/Disclaimer.asp Learn more about publishing your news release and our other news services on the Investorideas.com newswire https://www.investorideas.com/News-Upload/ and tickertagstocknews.com Global investors must adhere to regulations of each country. Please read Investorideas.com privacy policy: https://www.investorideas.com/About/Private_Policy.asp
Investor Ideas does not condone the use of cannabis except where permissible by law. Our site does not possess, distribute, or sell cannabis products.
Follow us on Twitter https://twitter.com/Investorideas
Follow us on Facebook https://www.facebook.com/Investorideas
Follow us on YouTube https://www.youtube.com/c/Investorideas
Download our Mobile App for iPhone and Android
Join our Investor Club https://www.investorideas.com/membership/
Contact Investorideas.com
800 665 0411
Get more Cannabis Stock Investor Ideas – news, articles, podcasts and stock directory
